These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38050692)

  • 1. Mortality of hospitalized patients with COVID-19: Effects of treatment options (vitamin D, anticoagulation, isoprinosine, ivermectin) assessed by propensity score matching, retrospective analysis.
    Plasek J; Dodulik J; Gai P; Hrstkova B; Skrha J; Zlatohlavek L; Vlasakova R; Danko P; Ondracek P; Cubova E; Capek B; Kollarova M; Furst T; Vaclavik J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Mar; 168(1):35-43. PubMed ID: 38050692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior use of therapeutic anticoagulation does not protect against COVID-19 related clinical outcomes in hospitalized patients: A propensity score-matched cohort study.
    Spiegelenberg JP; van Gelder MMHJ; Maas ML; Hovens MMC; Esselink A; Dofferhoff ASM; Janssen R; van de Maat J; Janssen N; Blaauw M; Hassing RJ; van Apeldoorn M; Kerckhoffs A; Veerman K; Hoogerwerf J; Kramers C; Leentjens J
    Br J Clin Pharmacol; 2021 Dec; 87(12):4839-4847. PubMed ID: 33899226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivermectin Effect on In-Hospital Mortality and Need for Respiratory Support in COVID-19 Pneumonia: Propensity Score-Matched Retrospective Study.
    Llenas-García J; Del Pozo A; Talaya A; Roig-Sánchez N; Poveda Ruiz N; Devesa García C; Borrajo Brunete E; González Cuello I; Lucas Dato A; Navarro M; Wikman-Jorgensen P
    Viruses; 2023 May; 15(5):. PubMed ID: 37243224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.
    Rajter JC; Sherman MS; Fatteh N; Vogel F; Sacks J; Rajter JJ
    Chest; 2021 Jan; 159(1):85-92. PubMed ID: 33065103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.
    Meizlish ML; Goshua G; Liu Y; Fine R; Amin K; Chang E; DeFilippo N; Keating C; Liu Y; Mankbadi M; McManus D; Wang SY; Price C; Bona RD; Ochoa Chaar CI; Chun HJ; Pine AB; Rinder HM; Siner JM; Neuberg DS; Owusu KA; Lee AI
    Am J Hematol; 2021 Apr; 96(4):471-479. PubMed ID: 33476420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoption of a National Prophylactic Anticoagulation Guideline for Hospitalized Pregnant Women With COVID-19: Retrospective Cohort Study.
    Hwang YM; Piekos S; Sorensen T; Hood L; Hadlock J
    JMIR Public Health Surveill; 2023 Jul; 9():e45586. PubMed ID: 37311123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 1-hydroxy-vitamin D treatment in hospitalized patients with COVID-19: A retrospective study.
    Ogasawara T; Tajima Y; Nakamura N; Kanasaki H; Matsuyama W; Niwa M; Ozawa Y; Sugiura M; Ogiku M; Sato J
    Clin Nutr; 2023 Oct; 42(10):2045-2050. PubMed ID: 37677909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic.
    Bartovská Z; Andrle F; Beran O; Zlámal M; Řezáč D; Murinova I; Holub M
    Epidemiol Mikrobiol Imunol; 2020; 69(4):164-171. PubMed ID: 33445940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an Arab Gulf country.
    Alguwaihes AM; Sabico S; Hasanato R; Al-Sofiani ME; Megdad M; Albader SS; Alsari MH; Alelayan A; Alyusuf EY; Alzahrani SH; Al-Daghri NM; Jammah AA
    Aging Clin Exp Res; 2021 May; 33(5):1415-1422. PubMed ID: 33788172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation Management and Outcomes in Patients With Covid-19 With Propensity Score Matching: A Multicenter Retrospective Cohort Study.
    Kaur J; deLongpre J; Koehler T; Laclair H; Bowen M; Khine J; Khosrodad N; Jena N; Dixit P; Yadav S; Mogulla SM; Coakley R; Sule A; Krishnamoorthy G
    Am J Ther; 2021 Nov; 29(1):e43-e49. PubMed ID: 34994348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: Multicentre randomized controlled clinical trial.
    Mariani J; Antonietti L; Tajer C; Ferder L; Inserra F; Sanchez Cunto M; Brosio D; Ross F; Zylberman M; López DE; Luna Hisano C; Maristany Batisda S; Pace G; Salvatore A; Hogrefe JF; Turela M; Gaido A; Rodera B; Banega E; Iglesias ME; Rzepeski M; Gomez Portillo JM; Bertelli M; Vilela A; Heffner L; Annetta VL; Moracho L; Carmona M; Melito G; Martínez MJ; Luna G; Vensentini N; Manucha W
    PLoS One; 2022; 17(5):e0267918. PubMed ID: 35622854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.
    Garcia PJ; Mundaca H; Ugarte-Gil C; Leon P; Malaga G; Chaccour C; Carcamo CP
    Trials; 2021 Apr; 22(1):262. PubMed ID: 33836826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of Ivermectin in COVID-19 patients: A prospective study at a safety-net hospital.
    Ozer M; Goksu SY; Conception R; Ulker E; Balderas RM; Mahdi M; Manning Z; To K; Effendi M; Anandakrishnan R; Whitman M; Gugnani M
    J Med Virol; 2022 Apr; 94(4):1473-1480. PubMed ID: 34811753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis.
    Meng Y; Lu W; Guo E; Liu J; Yang B; Wu P; Lin S; Peng T; Fu Y; Li F; Wang Z; Li Y; Xiao R; Liu C; Huang Y; Lu F; Wu X; You L; Ma D; Sun C; Wu P; Chen G
    J Hematol Oncol; 2020 Jun; 13(1):75. PubMed ID: 32522278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study.
    Denas G; Gennaro N; Ferroni E; Fedeli U; Lorenzoni G; Gregori D; Iliceto S; Pengo V
    Int J Cardiol; 2021 Apr; 329():266-269. PubMed ID: 33309764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
    Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.